Clonal Hematopoiesis Clinical Tool Identifies Those at Risk for Blood Cancer
A new clinical tool pinpoints which clonal hematopoiesis patients are at highest risk for cancer progression.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Cancer |
A new clinical tool pinpoints which clonal hematopoiesis patients are at highest risk for cancer progression.
Read MorePosted by Andy Lundin | Dec 2, 2022 | Hematology & Serology, Point-of-Care |
HemoSonics has received 510(k) market clearance from the U.S. FDA for the Quantra Hemostasis System with QStatCartridge.
Read MorePosted by Andy Lundin | Nov 28, 2022 | Sexually Transmitted Diseases |
Chembio announced the submission to the FDA for a Clinical Laboratory Improvement Amendments waiver for the DPP HIV-Syphilis System.
Read MorePosted by Chris Wolski | Nov 28, 2022 | Flow Cytometry, Lab Automation |
The ongoing clinical laboratory labor shortage is putting a strain on the U.S. healthcare system, but automation can help clinical labs cope.
Read MorePosted by Chris Wolski | Nov 23, 2022 | Molecular Diagnostics |
The October/November 2022 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
Read More